The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options

Wang, Qing, Luo, Yuqi, Ray Chaudhuri, K, Reynolds, Richard, Tan, Eng-King, Pettersson, Sven·2021·Brain

DOI 10.1093/brain/awab156

Cited by (280)

Items 101–200 of 280

Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial
Valentina Leta, Pavlos Zinzalias, Lucia Batzu, Gargi Mandal, Juliet Staunton, Frida Jernstedt, Kristina Rosqvist, Jonathan Timpka, Trinette van Vliet, Dhaval Trivedi et al. · 2025 · Movement Disorders
The Influence of the Gut Microbiota on Alzheimer's Disease: A Narrative Review
Jun-Ting Yin, Xiaowei Xu, Chen-Yang Jin, Xiaoying Yuan, Xugang Wang · 2023 · Journal of Integrative Neuroscience
Mendelian randomization reveals association between retinal thickness and non-motor symptoms of Parkinson’s disease
Hang Zhou, Bibiao Shen, Zifeng Huang, Shuzhen Zhu, Wanlin Yang, Fen Xie, Yuqi Luo, Feilan Yuan, Zhaohua Zhu, Chao Deng et al. · 2023 · npj Parkinson s Disease
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
Cristiana Vilela, Bruna Araújo, Carla Soares-Guedes, Rita Caridade-Silva, Joana Martins‐Macedo, Catarina Teixeira, Eduardo D. Gomes, Cristina Prudêncio, Mónica Vieira, Fábio Gabriel Teixeira · 2024 · Cells
Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson’s Disease: A Review of Inflammatory Markers and Potential Effects
Karol Artur Sadowski, Weronika Zając, Łukasz Milanowski, Dariusz Koziorowski, Monika Figura · 2024 · International Journal of Molecular Sciences
Microbial metabolite 3-indolepropionic acid alleviated PD pathologies by decreasing enteric glia cell gliosis via suppressing IL-13Rα1 related signaling pathways
Meiyu Shang, Jingwen Ning, Caixia Zang, Jingwei Ma, Yang Yang, Zhirong Wan, Jing Zhao, Yueqi Jiang, Qiuzhu Chen, Yirong Dong et al. · 2025 · Acta Pharmaceutica Sinica B
Novel PANK2 Mutations in Patients With Pantothenate Kinase-Associated Neurodegeneration and the Genotype–Phenotype Correlation
Wenbin Li, Nan-Xiang Shen, Chao Zhang et al. · 2022 · Frontiers in Aging Neuroscience
Parkinson’s disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies
Suhas Hajare, Yogesh Anant Kulkarni · 2025 · Brain Research
Neuroprotective Effects of Oligosaccharides From Periplaneta Americana on Parkinson’s Disease Models In Vitro and In Vivo
Miaomiao Liu, Nan Zhou, Na Jiang, Kaimin Lu, Chuanfang Wu, Jinku Bao · 2022 · Frontiers in Pharmacology
Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson’s Disease Mice via Inhibiting TLR4/NF-κB Signaling
Zhu-qing He, Peng-fei Huan, Li Wang, Jiancheng He · 2023 · Neurochemical Research
The pathogenesis of Parkinson’s disease and crosstalk with other diseases
Tingting Liu, DINGYOU GUO, Jianshe Wei · 2024 · Biocell
NLRP3/Caspase-1-Mediated Pyroptosis of Astrocytes Induced by Antipsychotics Is Inhibited by a Histamine H1 Receptor-Selective Agonist
Meng Xiao He, Jun Fan, Ruqin Zhou, Guanbin Gao, Ruoxi Li, Yu-feng Zuo, Benben Li, Yanmei Li, Taolei Sun · 2022 · Frontiers in Aging Neuroscience
Dopamine and the Gut Microbiota: Interactions Within the Microbiota–Gut–Brain Axis and Therapeutic Perspectives
Aurelia Cristiana Barbu, Smaranda Stoleru, Aurelian Zugravu, Elena Poenaru, Adrian-Florentin Dragomir, Mihnea Costescu, Sorina Maria Aurelian, Yara Shhab, Clara Maria Stoleru, Oana Andreia Coman et al. · 2025 · International Journal of Molecular Sciences
Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration
Sarmistha Mitra, Yeasmin Akter Munni, Raju Dash, Toma Sadhu, Largess Barua, Md. Ariful Islam, Dipannita Chowdhury, Debpriya Bhattacharjee, Kishor Mazumder, Il Soo Moon · 2023 · Life
Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease
Yingying Ding, Benson O. A. Botchway, Yong Zhang, Xuehong Liu · 2023 · Food & Function
Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson’s disease
Mohamed E. Ramadan, Tarek M. Mostafa, Azza Abbas Ghali, Dalia El‐Afify · 2025 · Inflammopharmacology
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Tong Guo, Li Chen · 2022 · European Journal of Inflammation
Herbal Interventions in Parkinson’s Disease: A Systematic Review of Preclinical Studies
Wanlin Zhao, Hailiang Cui, Jihong Liu, Hongyu Sun, Zijuan Zhang, Zhenqiang Zhang, Dongrui Ma · 2025 · Cellular and Molecular Neurobiology
The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's disease
Samuel Strader, Andrew B. West · 2023 · Biochemical Society Transactions
The Common Denominators of Parkinson’s Disease Pathogenesis and Methamphetamine Abuse
Bruno Vincent, Mayuri Shukla · 2023 · Current Neuropharmacology
Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications
Ian Richard Lucena Andriolo, Bruna Cristina Longo, Dayse Machado de Melo, Márcia María de Souza, Rui Daniel Prediger, Luísa Mota da Silva · 2024 · CNS & Neurological Disorders - Drug Targets
Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson’s disease
Piyush Padhi, Ahmed Abdalla, Benjamin Schneider, Nick Backes, Alyssa A. Otto, Ileia Scheibe, Jacob P. Thomas, Gargi Khadse, Manikandan Samidurai, Alexander K. Jochmans et al. · 2025 · Cell Host & Microbe
Neuroprotective effect of Bacillus subtilis in haloperidol induced rat model, targeting the microbiota-gut-brain axis
Monalisa Rout, Durga Madhab Kar, Debasmita Dubey, Sneha Kispotta, Prerna Sarangi, Shakti Ketan Prusty · 2024 · Journal of Molecular Histology
Chitosan lactate improves repeated closed head injury-generated motor and neurological dysfunctions in mice by impacting microbiota gut-brain axis
Mohd Rabi Bazaz, Hara Prasad Padhy, Manoj P. Dandekar · 2025 · Metabolic Brain Disease
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Dayamrita Kollaparampil Kishanchand, Athira Krishnan K. A., Krishnapriya Chandrababu, Cyriac Abby Philips, Unnikrishnan Sivan, P. S. Baby Chakrapani · 2025 · Journal of Neuroscience Research
Bifidobacterium infantis and Bifidobacterium breve Improve Symptomatology and Neuronal Damage in Neurodegenerative Disease: A Systematic Review
Manuel Reiriz, Ana Isabel Beltrán-Velasco, Víctor Echeverry‐Alzate, Esther Martínez Miguel, Silvia Gómez-Senent, Sara Uceda, Vicente Javier Clemente‐Suárez · 2025 · Nutrients
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated
Xue Bai, Gerard Batallé, Gianfranco Balboni, Olga Pol · 2022 · Antioxidants
Zeolite and Neurodegenerative Diseases
Stefan Panaiotov, Lyubka P. Tancheva, Reni E. Kalfin, Polina S. Petkova-Kirova · 2024 · Molecules
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
Jonah Gordon, Gavin Lockard, Molly Monsour, Adam Alayli, Hassan Choudhary, Cesar V. Borlongan · 2022 · International Journal of Molecular Sciences
Breast Cancer: How Hippotherapy Bridges the Gap between Healing and Recovery—A Randomized Controlled Clinical Trial
Hélène Viruega, Corinne Galy, Célia Loriette, Stéphane Jacquot, Jean Louis Houpeau, Manuel Gaviria · 2023 · Cancers
Improvements in Gut Microbiome Composition and Clinical Symptoms Following Familial Fecal Microbiota Transplantation in a Nineteen-Year-Old Adolescent With Severe Autism
Sabine Hazan, Jonathan M. Haroon, Sheldon Jordan, Stephen J. Walker · 2024 · Journal of Medical Cases
The Vagus Nerve and the Brain-Gut Axis: Implications for Neuropsychiatric Disorders
Wilfredo López-Ojeda, Robin A. Hurley · 2024 · Journal of Neuropsychiatry
Gut Microbiota and Neuroinflammation: An Interconnected Nexus of Health and Neurodegenerative Disease
Mega Obukohwo Oyovwi, Gregory Uchechukwu Joseph, Bolape Adeola Oyekanmi, Emmanuel Igho Odokuma, Ugushida Thankgod Ogenma · 2024 · OBM Neurobiology
Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson’s Disease and Frailty
Martina Montanari, Nicola Biagio Mercuri, Giuseppina Martella · 2024 · International Journal of Molecular Sciences
The role of the gut microbiota in neuropsychiatric disorders and therapy
Fan Zhang, Kang Ding, Linmei Zhang, Dongyao Liu, Xin Dong, Man‐Ni Wang, Fu-Lin Zhou, Yi‐Wei Sun, Wei‐Ku Zhang, Yan Yu et al. · 2025 · Ageing Research Reviews
The microbiota-gut-brain axis and three common neurological disorders: a mini-review
Amjad Mhanna, Zuheir Alshehabi · 2023 · Annals of Medicine and Surgery
Induction of autism-related behavior in male mice by early-life vitamin D deficiency: association with disruption of the gut microbial composition and homeostasis
Jingjing Cui, Shumin Wang, Zidan Zhai, Xiaoyue Song, Ting Qiu, Leilei Yu, Qixiao Zhai, Heng Zhang · 2024 · Food & Function
Gut microbiota-derived phenylacetylglutamine mitigates neuroinflammation induced by intracerebral hemorrhage in mice
Weiwei Zhang, Haopu Lin, Xuchao He, Qiuping Gu, Yan Ma, Xiongjie Fu, Linfeng Fan · 2025 · Journal of Stroke and Cerebrovascular Diseases
Assessing the relationship of gut microbiota with neurological, psychiatric, and neurodegenerative disorders: a narrative review
Maria Batagianni, Αndreas S. Papazoglou, Panagis Galiatsatos, Dimitrios A. Linos · 2025 · The World Journal of Biological Psychiatry
The Role of the Gut-Brain Axis in Diseases
Jing Wen Chen, Yijia Xu, Peng Cao · 2025 · Physiology
Sirtuins in Parkinson's disease: Molecular mechanisms and pathophysiological roles
Xiang Li, Xue‐Qun Luo, Xueqin Cao, Elizabeth Rosalind Thomas, Wenjun Wang, Xiaogang Zhou, Shiying Zhou, Anguo Wu, Ruixia Gao, Kezhi Liu et al. · 2025 · Ageing Research Reviews
A molecular convergence in the triad of parkinson’s disease, depressive disorder and gut health is revealed by the inflammation-miRNA axis
Lluís Miquel-Rio, Judith Jericó-Escolar, Claudia Yanes-Castilla, Unai Sarriés-Serrano, Verónica Paz, Luis Felipe Callado, J. Javier Meana, Analı́a A Bortolozzi · 2025 · Journal of Neuroinflammation
Correlation between dietary factors and Parkinson’s disease revealed by the analysis of Mendelian randomization
Shan Zeng, Aishanjiang Yusufujiang, Chunli Zhang, Yang Chen, Hongyan Li · 2024 · Frontiers in Nutrition
ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson’s disease mouse models
Fen Zhang, Lixin Pan, Changlin Lian, Zhifeng Xu, Hongda Chen, Wenjie Lai, Xiaojue Liang, Qiyuan Liu, Haomin Wu, Yukai Wang et al. · 2024 · Brain Research Bulletin
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
Chiara Sanluca, P. Spagnolo, Romina Mancinelli, Maria Ilenia De Bartolo, Marina Fava, Mauro Maccarrone, Simone Carotti, Eugenio Gaudio, Alessandro Leuti, Giorgio Vivacqua · 2024 · Metabolites
Gut microbial dysbiosis aggravated Parkinson-like pathology induced by MPTP/probenecid
Qiu-Zhu Chen, Junmei Shang, Yueqi Jiang, Yang Yang, Caixia Zang, Jingwei Ma, Yi-Rong Dong, JinRong Wang, Ning Zhou, Xing Yang et al. · 2025 · Physiology & Behavior
Iron mishandling in the brain and periphery in Parkinson’s disease
MacKenzie L. Bolen, Kelly B. Menees, Aidan C Dupreez, Malú G. Tansey · 2025 · npj Parkinson s Disease
Disease mechanisms as subtypes: Microbiome
Salvatore Bonvegna, Roberto Cilia · 2023 · Handbook of clinical neurology
Fibrinogen exacerbates α-synuclein aggregation and mitochondrial dysfunction via alpha5beta3 integrin in Parkinson’s disease
Zifeng Huang, Jialing Zheng, Feilan Yuan, Hui Zhong, Ruoyang Yu, Yuqi Luo, Muwei Zhang, Shuhan Chen, Bibiao Shen, Zhenchao Xie et al. · 2025 · Journal of Advanced Research
An Overview of Gastrointestinal Dysfunction in Parkinsonian Syndromes
Lauren S. Talman, Delaram Safarpour · 2023 · Seminars in Neurology
The microbiota-gut-brain axis in Huntington’s disease: Evidence, mechanisms and therapeutic opportunities
Yuxiu Gu, Mingxiao Wang, Ying Mao · 2026 · Frontiers in Neuroendocrinology
Gut dysbiosis and neurological modalities: An engineering approach via proteomic analysis of gut-brain axis
Meenakshi Kandpal, Nidhi Varshney, Kunal Sameer Rawal, Hem Chandra Jha · 2024 · Advances in protein chemistry and structural biology
Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder
Shuo Yang, Xiaojia Sun, Dianfeng Liu, Yiming Zhang, Xiyu Gao, Jiangmei He, Mingchi Cui, Shoupeng Fu, Dewei He · 2024 · Food & Function
Association between inflammatory bowel disease and Parkinson’s disease: a prospective cohort study of 468,556 UK biobank participants
Haili Wang, Zhiyun Wang, Jie Tian, Dongrui Ma, Changhe Shi · 2024 · Frontiers in Aging Neuroscience
Formononetin derived from Parabacteroides merdae alleviates MPTP-induced Parkinson’s disease in mice by inhibiting ferroptosis via the PI3K-AKT-ferritinophagy axis
Xuechao Dong, Teng Yang, Zheng Jin · 2025 · Communications Biology
Kynurenine pathway in Parkinson’s disease: pathophysiological roles and therapeutic interventions
Aganta Chakraborty, Priya Chaudhary, Joy Das, Utpal Bhui, Khadga Raj Aran, Md Sadique Hussain, Sumel Ashique, Biplab Debnath · 2025 · Inflammopharmacology
Interferon gamma stimulates coordinated changes in LRRK2, GCase, and cathepsin activities in idiopathic and genetic Parkinson’s disease monocytes
Laura P. Hughes, Rebecca L. Wallings, Julian Agin‐Liebes, Roy N. Alcalay, Alícia Garrido, Malú G. Tansey, Nicolas L. Dzamko · 2025 · npj Parkinson s Disease
Development of a Gastrointestinal-Myoelectrical-Activity-Based Nomogram Model for Predicting the Risk of Mild Cognitive Impairment
Baichuan Li, Shuming Ji, Anjiao Peng, Na Yang, Xia Zhao, Peimin Feng, Yun‐wu Zhang, Lei Chen · 2022 · Biomolecules
Targeting Emerging Pathogenic Mechanisms by Natural Molecules as Potential Therapeutics for Neurodegenerative Diseases
Yan Dou, Dongju Zhao · 2022 · Pharmaceutics
Stimulatory Effect of Lactobacillus Metabolites on Colonic Contractions in Newborn Rats
Constantin V. Sobol · 2022 · International Journal of Molecular Sciences
Kanamycin treatment in the pre-symptomatic stage of a Drosophila PD model prevents the onset of non-motor alterations
Daniela Molina‐Mateo, Benjamín Valderrama, Rafaella V. Zárate, Sergio Hidalgo, Javier Tamayo-Leiva, A. Soto-González, Simón Guerra, V. Arriagada-Vera, Carlos Oliva, Beatriz Dı́ez et al. · 2023 · Neuropharmacology
Probiotic Influences on Motor Skills: A Review
Robert Lalonde, C. Strazielle · 2023 · Current Neuropharmacology
Fecal Microbiota Underlying the Coexistence of Schizophrenia and Multiple Sclerosis in Chinese Patients
Li Shao, Jinlong Fu, Lulu Xie, Guangyong Cai, Yiwen Cheng, Nengneng Zheng, Ping Zeng, Xiumei Yan, Zongxin Ling, Shiwei Ye · 2023 · Canadian Journal of Infectious Diseases and Medical Microbiology
Sensitive colorimetric sensing of dopamine and TYR based on enhanced HRP-like activity of CuNi/Fe LDHs nanozymes
Fenghua Geng, Min Huang, Xiaoli Zhang · 2025 · Microchimica Acta
Parkinson’s disease and metabolic disorders, understanding their shared co-morbidity through the autonomic nervous system
Thanh Pham, Rebecca E Schelling, Ken H. Loh · 2025 · Advances in genetics
Gut–brain–immune axis implications for mental health and disease
Hadi Nasiri, Zahra Valedkarimi, Morteza Akbari · 2025 · Molecular and Cellular Biochemistry
Dysfunctional digestive tract highlights the metabolic hallmarks of nanoplastic-exacerbated Parkinson’s pathology
Xiufang Liang, Yue Wang, Nicholas Andrikopoulos, Pu Chun Ke, Yuhuan Li · 2025 · npj Parkinson s Disease
Artificial intelligence empowers gut microbiota research in neurodegenerative diseases molecular mechanisms and precision therapy
Hanyu Zhu, Haijun He, Ming Yang, Hanbing Zhu, Akifumi Hagiwara, Liting Shu, Jiangxingzi Xu, Yufang Miao, Xiaowei Han, C. Wang · 2025 · iScience
The Impact of Triangle Hierarchical Management on Self-Management Behavior and Quality of Survival in Parkinson's Patients
Yahua Zeng, Jianghua Huang, Xuan Rong Tang · 2022 · Frontiers in Surgery
Lactobacillaceae and Parkinson's disease: An apparent paradox
Marieke ME van der Maden, Marcel M. Verbeek, Milan Beckers · 2025 · Journal of Parkinson s Disease
Biofilm-associated proteins: from the gut biofilms to neurodegeneration
Jaione Valle · 2025 · Gut Microbes
RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases—advantages and limitations
Dorota Koníčková, Dominik Hraboš, Kateřina Menšíková, L. Tučková, Michal Kaleta, Miroslav Strnad, Carlo Colosimo, Petr Kaňovský · 2025 · Frontiers in Neurology
The Search for Disease Modification in Parkinson’s Disease—A Review of the Literature
Daniel Barber, Tissa Wijeratne, Lakshman Singh, Kevin Jeffrey Barnham, Colin Louis Masters · 2025 · Life
Gut Microbes in Parkinson's Disease
Anastasia Markidi, Joshua D. Elford, Celia R. Berkers, Aletta D. Kraneveld, Paula Perez‐Pardo · 2024 · Elsevier eBooks
Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids
Fatemeh Mirab, Mitra Pirhaghi, Daniel E. Otzen, Ali Akbar Saboury · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Treating Chronic Diseases by Regulating the Gut Microbiota
Bin Hong, Jian‐Dong Jiang · 2021 · Engineering
Exploring the relationship between novel Coronavirus pneumonia and Parkinson’s disease
Xiaoming Xi, Liang Han · 2022 · Medicine
Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease
Takuma Ohmichi, Takashi Kasai, Makiko Shinomoto, Fukiko Kitani‐Morii, Yuzo Fujino, Kanako Menjo, Toshiki Mizuno · 2023 · PLoS ONE
Influence of the Microbiota Through the Gut-Brain Axis in Neurological Diseases
Valentina Guarnotta, Francesco Vito Mandarino, Ernesto Fasulo, Marcello Fabio Maida, Liboria Laterza, Sandro Sferrazza, Dario Raimondo, Emanuele Sinagra · 2024 · Integrated science
Therapeutic role of probiotics in motor and non-motor symptoms of Parkinson’s disease
Salomón Páez‐García, Daniel Hernández-Triana, Félipe Esparza Salazar, George Emilio Barreto, María Cruz Rodríguez-Oroz, Miguel Germán Borda · 2025 · Exploration of Neuroprotective Therapy
Radiation-Induced Neurodegeneration
Marialuisa Zedde, Rosario Pascarella · 2026 · Biomedicines
Functional Medicine Approaches to Neurodegeneration
Datis Kharrazian · 2022 · Physical Medicine and Rehabilitation Clinics of North America
The influence of alterations in the composition of intestinal microbiota on neurovascular coupling and cognitive dysfunction in individuals afflicted with CSVD
Wei Zhang, Xianfeng Yu, Min Wei, Jie Zhou, Yajun Zhou, Xia Zhou, Kai Zhao, Xiaoqun Zhu · 2024 · Brain Research Bulletin
The interplay between gut microbiota composition and dementia
Rad Ghannadzadeh Kermani Pour, Sara Kamali Zounouzi, Melina Farshbafnadi, Nima Rezaei · 2025 · Reviews in the Neurosciences
Causal Relationship Between Intestinal Microbiota, Inflammatory Cytokines, Peripheral Immune Cells, Plasma Metabolome and Parkinson's Disease: A Mediation Mendelian Randomization Study
Chengcheng Wang, Yuhang Tang, Tao Yang, Yuhao Wang, Zihui Niu, Kang Zhang, Ning Lin, Qun Li · 2025 · European Journal of Neuroscience
Natural Products from Chinese Medicine Targeting NF-κB Signaling: Emerging Therapeutic Avenues for Neurodegenerative Diseases
Lihui Wang, Lina Feng, Baicheng Ning, Zhuolin Wang, Chunmei Dai, Mingquan Li · 2025 · Drug Design Development and Therapy
High-Throughput Screening of Microbial Isolates with Impact on Caenorhabditis elegans Health
Irtiqa Ali, Jack Martin, Alejandra Zárate-Potes, Alexandre Benedetto · 2022 · Journal of Visualized Experiments
Coexistence of Parkinson's disease and myasthenia gravis: A case report and literature review
Zhijuan Mao, Nie Qing, Zheng Xue, Zhijun Li · 2024 · Experimental and Therapeutic Medicine
Evaluation of the disease-modifying effects of Aureobasidium pullulans AFO-202 strain produced Beta-Glucan in Parkinson’s disease – Results of a pilot clinical study
Chockanathan Vetrievel, Allimuthu Nithyanandam, Subramaniam Srinivasan, Sudhakar S Bharatidasan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham · 2023 · medRxiv
Commentary: Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis
Takahiko Nagamine · 2024 · Frontiers in Immunology
On the Gut Microbiome as a Central Player in Aging: Mechanisms and Health Outcomes
A. A. Melnitskaia, Lubov V. Matchekhina, Ильющенко Анна Константиновна, Irina Dmitrievna Strazhesko · 2024 · Advances in Gerontology
Causal Relationships Between the Gut Microbiota, Inflammatory Cytokines, and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Analysis
Changqing Li, Yu Leying, Caiyun Ma, Hebao Wen, Laiguo Han, Xiaojiang Zhao · 2025 · Brain and Behavior
Lower prevalence of metabolic syndrome and its components in the prediagnostic phase of Parkinson’s disease
Hila Avisar, Uri Greenbaum, Ruth Djaldetti, Boaz Lerner · 2025 · npj Parkinson s Disease
Potentials of cepharanthine and tomatidine as novel LpxC and TLR4 inhibitors to mitigate gut-mediated inflammation in Parkinson’s disease: a high-throughput investigation through molecular docking and dynamic simulation
Rubina Roy, Indira Gahatraj, Anupama Sharma, Vishal Kumar, Rajib Kumar Paul, Diwakar Kumar, Pallab Bhattacharya, Anupom Borah · 2025 · 3 Biotech
Parasite-mediated alteration of behaviour and biomolecular dynamics in a mouse model
Steven Santino Leonardi, Chin Wen Png, Aye Sandi Bo, Peiyan Wong, Vinaya Rajagopal Iyer, Kevin S. W. Tan · 2025 · Frontiers in Cellular and Infection Microbiology
Gut microbiome signatures in iNPH: Insights from a shotgun metagenomics study
Rahel Park, Claire Chevalier, Silas Kieser, Moira Marizzoni, Arthur Paquis, Stéphane Armand, Max Scheffler, Gilles Allali, Frédéric Assal, Shahan Momjian et al. · 2025 · PLoS ONE
Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease
Faezeh Hatami, Zahra Aghelan, Majid Pouya, Melina Moulaeian, Ali Asghar Rastegari, Seyed Hosein Abtahi, Shaghayegh Hoseini · 2025 · Metabolic Brain Disease
Mitochondrial Calcium Channels and MAM Interaction in Calcium Homeostasis Dysregulation in Parkinson’s Disease
Bingjie Han, Jie Bai · 2025 · Neurochemical Research
Therapeutic Efficacy of Curcumin Nanoparticles in Parkinson’s Disease: An Integrated Analysis of Network Pharmacology, Experimental Validation, and Gut Microbiota
Runhong Mu, Tengda Liu, Yu Zhang, Kexin Xiu, Xiao Guo, Wei Xia · 2026 · Drug Design Development and Therapy
GPR3 in neuro-metabolic-immune-reproductive nexus – a potential therapeutic target for Multi-System diseases
Bi-Dan Feng, Jiyao Qin, Qian-qiong Qin, Zui-Cai Xu, Haiqing Zhang · 2026 · Annals of Medicine